This article explores the 20 mid-cap stocks insiders were buying in Q1 2025. Previously, we covered the 20 small-cap stocks insiders were buying in Q1 2025.
Stock markets tumbled on Wednesday, with technology shares leading the slide amid growing concerns over ever-changing tariffs. The broader market index dropped 2.2%, the blue-chip companies fell by almost 700 points, a decline of 1.7%, and the Nasdaq Composite —dominated by tech—plunged nearly 3.1%. With this decline, the Nasdaq is now about 19% below its recent peak, edging closer to bear market territory.
Stocks dropped to their lowest levels of the day Wednesday after Fed Chair Jerome Powell warned that the tariffs could increase short-term inflation. He noted the Federal Reserve might face a tough situation where its goals of full employment and stable prices may come into conflict, according to CNBC.
During periods of market and economic uncertainty, insider trading often draws increased interest. Executive stock purchases can suggest confidence in the company’s outlook, while sales may simply reflect personal financial needs or efforts to diversify investments. Many executives use pre-established trading plans, such as 10b5-1 programs, which are designed to remove timing decisions from the equation. To get a clearer picture, insider activity should be evaluated alongside the company’s overall financial health and broader market conditions.
An array of Japan exchange listed fund symbols on a large trading screen.
Our Methodology
Today, we’re focusing on stocks that have seen heavy insider buying activity in the first quarter of the year. Using Insider Monkey’s insider trading screener, we identified companies with market caps between $2 billion and $10 billion, where at least two insiders purchased shares in the past three months. From this list, we ranked the top 20 stocks with the highest value of insider purchases. Most of the stocks that have been recently covered were excluded from our analysis.
Our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds, focusing on insider trading and stock picks from hedge fund investor newsletters and conferences. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).
For each stock, we note the number of insiders who acquired shares in the first quarter and the market capitalizations. Let’s take a look at the 20 mid-cap stocks insiders were buying in Q1 2025.
20. Arcosa, Inc. (NYSE:ACA)
Market Cap: $3.77 billion
Arcosa provides infrastructure products and solutions for the construction, engineered structures, and transportation markets in the U.S. It operates through three segments: Construction Products (offering aggregates and construction equipment), Engineered Structures (providing utility structures, wind towers, and more), and Transportation Products (offering inland barges and marine equipment).
In March, three insiders, including the company’s CEO, Antonio Carrillo, acquired $618,191 worth of Arcosa shares at an average price of $79.14 per share. Carrillo bought 200 shares, increasing his ownership to 433,283 shares. Currently, the stock trades at $77.17 per share, having lost 20.23% year-to-date. However, over the past 12 months, the stock gained 0.39%.
Arcosa reported fourth-quarter revenue of $666.2 million, a 14% increase from $582.2 million in Q4 2023. For the full year, revenue grew 11%, reaching $2.57 billion compared to $2.31 billion in 2023. The Construction Products segment saw a 31% revenue increase, partly driven by recent acquisitions like Stavola Holding Corp., while organic revenues declined by 4% due to lower freight revenue and the sale of underperforming operations.
For 2025, the company expects revenues between $2.8 billion and $3 billion, with adjusted EBITDA ranging from $545 million to $595 million, reflecting a 30% growth at the midpoint. The guidance includes both organic and inorganic growth, with a slightly higher emphasis on inorganic growth due to nine additional months of Stavola in 2025.
According to MarketBeat, four analysts rate Arcosa stock as “Buy” with a price target of $105.50 per share. This suggests a potential upside of 36.44% from the latest price.
19. Alight, Inc. (NYSE:ALIT)
Market Cap: $2.74 billion
Alight is a global technology-enabled services company that offers Alight Worklife, a cloud-based employee engagement platform. Its services include benefits administration, healthcare navigation, financial well-being, leave management, and retiree healthcare, along with AI-driven software. Founded in 2020, Alight is headquartered in Chicago, Illinois. It is also one of the 10 best low cost stocks to buy according to billionaires.
Recently, Alight has been recognized as one of America’s Greatest Workplaces for Mental Wellbeing in 2025 by Newsweek and Plant-A Insights Group. This recognition follows a rigorous evaluation based on publicly available data, HR professional interviews, and large-scale surveys of U.S. employees.
In March, three insiders acquired approximately $808,170 worth of Alight shares at an average price of $6.48 per share. The stock is now trading at $4.96 per share, dropping 28.40% year-to-date, and 45.19% over the past 12 months.
According to MarketBeat, eight analysts rate Alight stock as a “Moderate Buy” with the average price target of $10.19, suggesting a potential upside of 105.60% from the current price.
18. RLI Corp. (NYSE:RLI)
Market Cap: $7.12 billion
RLI is a property and casualty insurance company offering coverage for both commercial and personal needs, including general liability and environmental risks.
On February 13, RLI Corp.’s Board of Directors declared the first-quarter cash dividend of $0.15 per share, a 3.4% increase from the previous quarter. This marks the company’s 50th consecutive year of dividend increases. In Q4 2024, RLI reported net earnings of $40.9 million ($0.44 per share), down from $114.6 million ($1.24 per share) in Q4 2023.
In January, five insiders—including the CEO and COO—purchased nearly $950,000 worth of RLI shares at an average price of $72.14, with CEO W. Craig Kliethermes buying 5,000 shares, bringing his total shares to 139,190.
In a recent development, RLI Transportation partnered with TruckerCloud, a tech company specializing in onboard camera and telematics data integration. This collaboration will give RLI a unified telematics insights solution, helping create more proactive and personalized safety and risk management programs for its commercial transportation clients.
According to seven analysts, RLI stock is a “Hold” with an average price target of $79.80, reports MarketBeat.
17. Bruker Corporation (NASDAQ:BRKR)
Market Cap: $5.52 billion
Bruker Corporation develops and sells scientific instruments and diagnostic solutions worldwide, operating through four segments: BioSpin, CALID, Nano, and Energy & Supercon Technologies. Its products include tools for magnetic resonance, mass spectrometry, molecular diagnostics, X-ray analysis, atomic force microscopy, and advanced imaging technologies. Founded in 1960, Bruker is headquartered in Billerica, Massachusetts.
In February and March, two insiders, including the company’s CEO, purchased around $1.04 million worth of Bruker shares at an average price of $49.79 per share. Currently, the stock trades at $36.41, having lost 37.89% since the beginning of the year, and 56.09% over the past 12 months.
Bruker Corporation recently launched the nVista 2P, a lightweight two-photon miniscope designed for high-resolution imaging of brain activity in freely moving animals. Weighing just 2 grams, it captures 3D, single-cell resolution images up to 300 microns deep, making it ideal for studying neural circuits in regions like the entorhinal cortex and hypothalamus. The device supports both shallow and deep brain imaging using existing one-photon protocols.
According to MarketBeat, 11 analysts rate Bruker stock as a “Moderate Buy” with an average price target of $66.50.
Bruker is also one of the 7 best medical technology stocks to buy according to analysts.
16. Noble Corporation plc (NYSE:NE)
Market Cap: $3.17 billion
Noble Corporation is an offshore drilling contractor providing drilling services to the oil and gas industry around the world. The company operates a fleet of offshore rigs, including floaters and jack-up rigs. Founded in 1921, Noble Corporation is headquartered in Houston, Texas.
In Q4 2024, Noble Corporation reported $882 million in contract drilling revenue, up from $764 million in Q3, mainly due to its Diamond Offshore acquisition. Net income rose to $97 million, and Adjusted EBITDA increased to $319 million, including $40 million from the early termination of the Noble Deliverer. Despite higher costs and capital expenditures, the company generated $136 million in operating cash flow and $2 million in free cash flow.
In February and March, two insiders, including the company CEO, and CFO, bought around $1.05 million worth of Noble shares at an average price of $25.92 per share. Year-to-date, the stock is down 36.56%, trading at $19.92 per share. Over the past 12 months, Noble stock dropped 56.89%.
Noble stock has an average “Buy” rating from seven analysts, according to StockAnalysis. The 12-month price forecast is $33.83, suggesting a 69.92% potential increase from its latest price.
15. The Macerich Company (NYSE:MAC)
Market Cap: $3.85 billion
The Macerich Company owns 43 million square feet of real estate, including 40 regional retail centers in key U.S. markets. Its portfolio is focused in areas like California, the Pacific Northwest, Phoenix/Scottsdale, and the Metro New York to D.C. corridor.
Recently, Macerich signed a multi-year sponsorship and engagement deal with PenFed Credit Union to enhance branding at Tysons Corner Center. The agreement will boost the center’s marketing programs and media reach, engaging millions of shoppers and PenFed members. The outdoor space formerly known as “The Plaza” will now be called “PenFed Plaza at Tysons Corner Center.”
In March, two insiders, including the president and CEO, acquired around $1.11 million worth of The Macerich shares at an average price of $17.08 per share. Year-to-date, the stock is down 26.91%, trading at $14.56 per share. Over the past 12 months, its shares have lost 5.27%.
The Macerich stock has an average “Hold” rating from 12 analysts, with a price target of $18.62, suggesting a 27.19% potential upside, according to StockAnalysis.
14. Charles River Laboratories International, Inc. (NYSE:CRL)
Market Cap: $5.13 billion
Charles River Laboratories offers drug discovery, non-clinical development, and safety testing services globally. The company operates in three segments: Research Models and Services (providing lab animals and related services), Discovery and Safety Assessment (offering preclinical drug testing), and Manufacturing Solutions (providing quality control testing for pharmaceuticals). Founded in 1947, Charles River is headquartered in Wilmington, Massachusetts. It is also one of the 12 best diagnostics stocks to invest in right now.
In a recent development, Charles River Laboratories and Valo Health have identified a promising product candidate for treating lupus and other autoimmune conditions. This discovery is the first made using Logica, an AI-powered drug development solution that turns biological insights into optimized preclinical assets.
On February 20, the company CEO and COO acquired approximately $1.25 million worth of Charles River shares at an average price of $164.82 per share. Currently, the stock trades at $104.49, having dropped 43.40% year-to-date, and 54.49% over the past 12 months.
According to StockAnalysis, Charles River stock has an average “Hold” rating from 15 analysts. The 12-month price forecast is $185.77, indicating a 77.48% potential increase from its latest price.
13. Clarivate Plc (NYSE:CLVT)
Market Cap: $2.36 billion
Clarivate is a UK-based information services company that provides data, analytics, and workflow solutions to customers in academia, life sciences, healthcare, and intellectual property sectors worldwide. Its offerings include research platforms like ProQuest One, library services like Alma and Vega, and IP management tools such as IPFolio and CompuMark. Clarivate serves universities, corporations, law firms, and government agencies, helping them manage data, research, and innovation efficiently. It is also one of the 13 best technology penny stocks to buy right now.
The company recently confirmed its expansion of the Academic AI Platform to help researchers, students, and staff work more efficiently using AI tools. Beginning in April 2025, it will introduce AI Agents to support academic workflows and launch a Development Partner Program to create community-driven AI tools. The platform will continue to prioritize academic needs, integrity, and human oversight.
In March, four insiders bought around $1.54 million worth of Clarivate shares at an average price of $4.24 per share. Year-to-date, the stock is down 32.48%, trading at $3.43 per share. Over the past 12 months, the stock dropped 50.36%.
According to MarketBeat, four analysts rate Clarivate stock as “Hold” with a price target of $5.83.
12. Helmerich & Payne, Inc. (NYSE:HP)
Market Cap: $2.02 billion
Helmerich & Payne is a Tulsa-based company that provides drilling solutions and technologies for oil and gas exploration, operating across North America, the Gulf of Mexico, and internationally. It focuses on improving drilling efficiency and wellbore quality through advanced technologies. The company also owns commercial real estate, including a shopping center.
In February, three insiders, including the company’s president and CEO, bought around $1.66 million worth of Helmerich & Payne shares at an average price of $26.96 per share. The company’s CEO acquired 20,000 shares, making his first purchase in almost eight years and increasing his ownership to 691,214 shares. Currently, the stock trades at $20.32 per share, having declined 36.54% since the beginning of the year and 50.26% over the past 12 months.
The company recently completed its acquisition of KCA Deutag as part of its international growth strategy. This move is expected to enhance profitability by strengthening cash flow, expanding global presence, and increasing scale and diversification.
According to 11 analysts, Helmerich & Payne stock is a “Hold” with an average price target of $31.78, reports MarketBeat. The average price target suggests a forecasted upside of 56.05% from the latest price.
Helmerich & Payne is also one of the 10 oversold stocks to buy in 2025 amid inflation fears.
11. Northern Oil and Gas, Inc. (NYSE:NOG)
Market Cap: $2.34 billion
Northern Oil and Gas, Inc., based in Minnetonka, Minnesota, is an independent energy company focused on acquiring and developing crude oil and natural gas properties across the U.S.
In March, three insiders purchased approximately $1.74 million worth of Northern Oil and Gas shares at an average price of $27.93 per share. The stock now trades at $23.81 per share, having dropped 35.93% year-to-date, and 43.91% over the past 12 months.
In the fourth quarter of 2024, Northern Oil and Gas produced 131,777 Boe per day, up 15% from the previous year, and generated $290.3 million in GAAP cash flow from operations. The company reported $96.4 million in free cash flow, spent $258.9 million on capital expenditures, and completed a $511.3 million acquisition in the Uinta Basin. During the quarter, Northern Oil and Gas also increased its quarterly dividend by 12.5% to $0.45 per share, and repurchased nearly 694,000 shares at an average price of $36.28.
According to MarketBeat, 10 analysts rate Northern Oil and Gas stock as a “Moderate Buy” with an average price target of $44.78.
10. Match Group, Inc. (NASDAQ:MTCH)
Market Cap: $7.18 billion
Match Group provides digital dating services through a portfolio of popular apps like Tinder, Hinge, OkCupid, and Plenty of Fish. It operates globally across four segments and supports users in over 40 languages. The company ranks 10th among the 20 mid-cap stocks insiders were buying in Q1 2025, and it is also one of the 10 cheap internet stocks to buy according to hedge funds.
In February, two insiders, including the company’s CEO purchased a total of $2.15 million worth of Match Group shares at a price of $34.44 per share. Currently, the stock trades at $28.93 per share, having lost 11.57% year-to-date, and 10.36% over the past 12 months.
In 2024, Match Group reported $3.5 billion in revenue, up 3% year-over-year, driven by an 8% increase in revenue per payer but offset by a 5% decline in total payers. Operating income dropped 10% to $823 million, while adjusted operating income remained flat at $1.3 billion. The company generated $882 million in free cash flow, repurchased $753 million worth of shares, and reduced its diluted shares outstanding by 7%.
According to estimates from 23 analysts, Match Group stock is rated a “Hold” with a price target of $37.63, reports MarketBeat.
9. Amentum Holdings, Inc. (NYSE:AMTM)
Market Cap: $4.55 billion
Amentum Holdings provides engineering and technology solutions to U.S. and allied government agencies, offering services across various sectors including energy, defense, intelligence, and space. The company, founded in 2023, is headquartered in Chantilly, Virginia.
In February, two insiders purchased around $2.18 million worth of Amentum shares at an average price of $21.02 per share. Currently, the stock trades at $18.70 per share, having lost 11.98% year-to-date. Since its IPO in September 2024, Amentum Holdings stock dropped 36.63%.
For the first quarter of fiscal 2025, Amentum reported revenues of $3.4 billion, compared to $3.3 billion in the same period of fiscal 2024. Adjusted EBITDA amounted to $262 million, which compares to $255 million in the prior year period.
Seven analysts rate Amentum stock as a “Hold” with a price target of $24.71 per share, according to MarketBeat.
8. Sonoco Products Company (NYSE:SON)
Market Cap: $4.28 billion
Sonoco Products Company designs, manufactures, and sells sustainable packaging products across the U.S., Europe, Canada, and the Asia Pacific. It operates in two segments: Consumer Packaging, which provides rigid paper and plastic containers, and Industrial Paper Packaging, which offers paperboard tubes and protective packaging. The Sonoco, South Carolina-based company serves a variety of industries including food, textiles, and construction.
Recently, Sonoco’s board of directors increased its quarterly dividend to $0.53 per share, marking the 100th consecutive year of dividend payments.
During the first quarter of 2025, three insiders, including the company’s CEO, acquired around $2.18 million worth of shares at an average price of $47.05 per share. The CEO, Howard R. Coker, accounted for $1.85 million of the purchase, increasing his holdings to 482,365 shares. Year-to-date, the stock is down 11.12% trading at $43.42 per share. Over the past 12 months, the stock dropped 22.17%.
Six analysts rate Sonoco Products stock as a “Moderate Buy” with a price target of $58.50, suggesting a potential upside of 34.64%, according to MarketBeat.
7. Ashland Inc. (NYSE:ASH)
Market Cap: $2.34 billion
Ashland, headquartered in Wilmington, Delaware, is a specialty materials company that operates through four segments: Life Sciences, Personal Care, Specialty Additives, and Intermediates. It provides ingredients and solutions for pharmaceuticals, personal care, coatings, construction, energy, food and beverage, and other industrial markets. Ashland is also one of the 11 most expensive stocks insiders are buying recently.
On January 31, two company insiders, one of whom was CEO Guillermo Novo, purchased Ashland stock totaling $2.21 million at an average price of $64.12 per share. The CEO accounted for the bulk of the purchase, acquiring 31,294 shares valued at approximately $2.01 million. This was Novo’s first purchase in nearly five years. Year-to-date, the stock is down 30.66%, trading at $49.55 per share. Over the past 12 months, the stock has dropped 47.23%.
In the first quarter of fiscal 2024, Ashland reported $405 million in sales, a 14% decrease from the same quarter in 2023. The company posted a net loss of $165 million, a sharp decline from the $26 million profit reported a year earlier. During the quarter, Ashland also entered into a definitive agreement to divest its Avoca business.
Six analysts rate Ashland stock as a “Moderate Buy” with a price target of $73.20 per share, suggesting an upside of 47.91% from the latest price.
6. FMC Corporation (NYSE:FMC)
Market Cap: $4.65 billion
FMC Corporation is a Philadelphia-based agricultural sciences company that provides crop protection solutions, including insecticides, herbicides, fungicides, and biologicals, to farmers worldwide. It sells its products through direct sales, partners, and distributors to help improve crop yield and quality. FMC Corporation is also one of the 14 best farmland and agriculture stocks to buy now.
Recently, FMC Corporation received regulatory approval in Peru for Keenali, the first commercial herbicide powered by its new active ingredient, Dodhylex (tetflupyrolimet). This marks the first global registration of a Group 28 herbicide, a new classification recognized by HRAC and WSSA.
In another recent development, the company received registration in Brazil for Sofero Fall, a pheromone product targeting fall armyworms in row crops. It’s the company’s first pheromone solution for large-scale farming, offering a sustainable way to control pests and improve productivity.
In March, three insiders, including the company’s chairman and CEO, bought around $2.36 million worth of FMC Corporation shares at an average price of $36.34. The company’s CEO, Pierre Brondeau, acquired 54,000 shares, making his first purchase in nearly five years, increasing his ownership to 298,439 shares. On February 5, the stock had a sharp drop of 33.56% falling from $54.04 per share to $35.92 per share. Year-to-date, the stock is down 23.35%, currently trading at $37.26 per share.
According to MarketBeat, 14 analysts rate FMC stock as “Hold” with an average price target of $50.31.
5. Murphy Oil Corporation (NYSE:MUR)
Market Cap: $2.94 billion
Murphy Oil Corporation is an independent oil and gas exploration and production company operating in the U.S., Canada, and internationally. It focuses on producing crude oil, natural gas, and natural gas liquids. The Houston, Texas-based company ranks fifth among 20 mid-cap stocks insiders were buying in Q1 2025.
In a recent development, Murphy Oil announced that its subsidiary will acquire the BW Pioneer FPSO from BW Offshore for $125 million, with approximately $100 million payable upon delivery by the end of Q1 2025. The remaining amount will be paid once contractual conditions are fulfilled, expected by the end of Q2 2025. Murphy also reaffirmed its 2025 capital expenditure guidance of $1.135–$1.285 billion, including $425 million for Q1.
On April 2, the company’s board of directors declared a quarterly cash dividend on the common stock of $0.325 per share or $1.30 per share on an annualized basis.
In February and March, three insiders, including the vice president, purchased approximately $2.93 million worth of Murphy Oil shares at an average price of $25.30 per share. Currently, the stock trades at $20.59, having dropped 31.96% year-to-date, and 54.53% over the past 12 months.
According to StockAnalysis, Murphy Oil stock has an average “Hold” rating from 13 analysts, with a price target of $32.83 — a 59.45% upside from the current price.
4. Atlas Energy Solutions Inc. (NYSE:AESI)
Market Cap: $2.27 billion
Atlas Energy Solutions is a leading provider of frac sand and logistics services for the oil and gas industry, serving customers in the Permian Basin of West Texas and New Mexico. The company produces and sells proppant used in hydraulic fracturing and offers transportation, storage, and labor solutions. Founded in 2017 and based in Austin, Texas, Atlas focuses exclusively on supporting oil and gas operations in North America’s most active energy region.
In February, two insiders, including the executive chairman, purchased around $5.61 million worth of Atlas Energy shares at an average price of $21.02 per share. Currently, the stock trades at $13.66, having dropped 38.41% since the beginning of the year.
For the year ended December 31, 2024, Atlas Energy’s total sales increased by 72%, reaching $1.1 billion, driven by a 270.7% increase in service sales. The company’s cost of sales rose significantly by 178.5% to $725.2 million, mainly due to higher product and service sales, operational issues, and acquisition costs. Net income for the year was $59.9 million, with Adjusted EBITDA at $288.9 million.
According to MarketBeat, eight Wall Street analysts rate Atlas Energy stock as a “Moderate Buy” with a price target of $22.50, suggesting a 64.71% potential upside.
Atlas Energy is also one of the 11 best mid-cap value stocks to buy according to analysts.
3. Millrose Properties, Inc. (NYSE:MRP)
Market Cap: $3.89 billion
Millrose acquires and develops residential land, then sells finished homesites to homebuilders through option contracts, supporting their asset-light strategies while continuously reinvesting capital into new land acquisitions.
On February 7, Lennar Corporation (NYSE:LEN) completed the spin-off of Millrose Properties, distributing approximately 80% of Millrose’s stock to its shareholders. Lennar stockholders received one share of Millrose stock for every two shares they owned, with special handling for fractional shares.
Following the spin-off, Millrose Properties has completed its $900 million acquisition of around 24,000 homesites from Rausch Coleman Homes and signed option agreements with Lennar for all of them. The deal was funded with Millrose’s cash on hand, and the company still has about $1.3 billion in available credit.
On March 17, Millrose Properties announced its first dividend of $65 million, or $0.38 per share, to be paid on April 15, 2025, to shareholders of record as of April 4. This pro-rated “stub” dividend covers the period from its February 7 spin-off from Lennar through March 31 and equates to $0.65 per share on a full quarterly basis.
In February and March, six insiders, including the company’s COO, acquired a total of $6.52 million worth of Millrose Properties shares at an average price of $22.70 per share. Since the February spin-off, Millrose Properties shares have gained 6.65%, trading at $23.40.
According to MarketBeat, two analysts rate Millrose Properties stock as a “Strong Buy”, with an average price target of $27.50.
2. Amkor Technology, Inc. (NASDAQ:AMKR)
Market Cap: $3.99 billion
Amkor, based in Tempe, Arizona, offers outsourced semiconductor packaging and testing services across the U.S., Japan, Europe, and the Asia Pacific region. Its services include wafer processing, package design, and final system-level testing. Amkor is also one of the 12 stocks that are about to explode.
In February, five insiders purchased a total of $95 million worth of Amkor Technology shares at an average price of $21.85 per share. Currently, the stock trades at $16.15 per share, having dropped 37.14% since the beginning of the year and 46.35% over the past 12 months.
For the full year 2024, Amkor generated $6.32 billion in net sales, slightly down from $6.50 billion in 2023. Net income totaled $354 million, or $1.43 per diluted share, compared to $360 million, or $1.46 per share, the year before.
In February, the company’s board of directors approved a quarterly cash dividend of $0.08269 per share on the company’s common stock.
According to StockAnalysis, seven analysts rate Amkor stock as “Buy” with a price forecast of $31.71, suggesting a 96.35% upside.
1. F&G Annuities & Life, Inc. (NYSE:FG)
Market Cap: $4.64 billion
F&G Annuities & Life ranks first among the 20 mid-cap stocks insiders were buying in Q1 2025. The Des Moines, Iowa-based company provides a range of annuity and life insurance products in the U.S., including fixed indexed annuities, indexed universal life insurance, and pension risk transfer solutions. It serves both retail and institutional clients through independent agents, banks, and broker-dealers.
In Q4, F&G reported net earnings attributable to common shareholders of $323 million ($2.50 per share), a sharp turnaround from a $299 million loss ($2.41 per share) in Q4 2023. For the full year, net earnings reached $622 million ($4.88 per share), compared to a $58 million loss ($0.47 per share) in the prior year. Adjusted net earnings, which exclude mark-to-market effects and one-time items, were $143 million ($1.12 per share) in Q4 and $546 million ($4.30 per share) for the full year—both up significantly from 2023.
In March, four insiders, including the company’s CEO, acquired a total of $152.62 million worth of F&G shares at an average price of $35.25 per share. The CEO, Christopher Blunt, made his first purchase in 17 months, acquiring a total of 30,000 shares, increasing his ownership to 849,584 shares. Year-to-date, the stock is down 16.84% trading at $34.46 per share, while over the past 12 months, the stock dropped 2.38%.
Two Wall Street analysts rate F&G stock as “Hold” with a price target of $40.00, according to TipRanks.
Overall, FG ranks first among the 20 mid-cap stocks insiders were buying in Q1 2025. While we acknowledge the potential of FG, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than FG but that trades at less than 5 times its earnings, check out our report about this cheapest AI stock.
READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.
